Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1744-6155.2008.00133.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exparel and Outpatient Alveolar Bone Grafting: A Feasibility Study.
Cleft Palate Craniofac J
January 2025
Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, NY, USA.
Objectives: To examine the feasibility of outpatient alveolar bone grafting (ABG) using Exparel (bupivacaine liposome injectable suspension) for donor site analgesia.
Design: Retrospective, observational study.
Setting: Single institution, 39-month retrospective review.
Comparative Investigation of the Nutritional Profiling and Antipyretic Activity of Leaves, Bark, and Root From Different Sites of Punjab, Pakistan.
Food Sci Nutr
January 2025
Department of Genetics and Animal Breeding, Faculty of Animal Science and Veterinary Medicine Patuakhali Science and Technology University Patuakhali Bangladesh.
The utilization of various plant sections as a medicinal and nutritional source for humans and animals has been the subject of significant research in recent years. This study aimed to investigate the nutritional profiling through proximate analysis and the antipyretic activity of leaves, bark, and root in methanolic extract from different sites of Punjab, Pakistan. Methanolic extract of leaves, bark, and root from sites i to e of Southern Punjab, Central Punjab, and Northwest Punjab as S1, S2, and S3, respectively, at doses of 50, 100, and 150 mg/kg bw showed statistically significant results as compared to the positive and negative controls.
View Article and Find Full Text PDFHow Much Pain Medication Do Patients Require After Posterior Iliac Crest Bone Graft to the Alveolar Cleft?
Cleft Palate Craniofac J
January 2025
Plastic and Oral Surgery, Boston Children's Hospital, Boston, Massachusetts, USA.
Objective: The purpose of this study was to quantify analgesic use following alveolar cleft bone grafting (ABG) utilizing a posterior iliac crest (PIC) donor site.
Design: This is a prospective cohort study of consecutive patients that underwent ABG with PIC in a 10 month period from November 2022 to September 2023.
Setting: Tertiary care free-standing pediatric hospital.
Urinary Acetaminophen Metabolites and Clinical Outcomes in Extremely Premature Infants.
Am J Perinatol
January 2025
Pediatrics, University of California San Francisco, San Francisco, United States.
Objective: Extremely premature infants are treated with acetaminophen (APAP) for pain and patent ductus arteriosus. High doses of APAP in adults are toxic, and a recent study found an association between APAP metabolite levels in mothers' breast milk and both bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) in their premature infants. In this study, we determined levels of APAP metabolites in urine of infants at high risk for BPD and ROP.
View Article and Find Full Text PDFThe Utilization of Acetaminophen for Managing PGE1-Induced Fever in Neonates with Critical Congenital Heart Disease.
Children (Basel)
December 2024
Department of Neonatology, SBU. Dr. Sami Ulus Maternity and Child Research and Training Hospital, Babur St., Number: 36, Altındag 06080, Turkey.
Introduction: We aimed to retrospectively evaluate the use of acetaminophen, which may be a risk factor for the ductal canal, in the treatment of fever due to prostaglandin E1 (PGE1) infusion in newborns with critical congenital heart disease (CCHD).
Methods: The study included newborns who were followed-up in our neonatal intensive care unit with the diagnosis of critical congenital heart disease, developed fever due to PGE1 infusion and had acetaminophen administered for antipyretic treatment. The patent ductus arteriosus diameters of the patients were evaluated by echocardiographic imaging before intravenous acetaminophen treatment and at the end of the day of acetaminophen treatment.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!